🟢 Cybin Inc. is trading 6% up today as it rebounds from recent weakness

Cybin Inc. is trading 6% up at $4.25 in pre-market, rebounding from recent weakness following several consecutive down sessions last week.

• The move lacks a clearly identifiable company-specific catalyst, with no fresh headlines, earnings releases, or FDA decisions reported for June 9, 2026.
• Current price action likely reflects typical low-liquidity pre-market volatility and a modestly supportive broader risk tone.